Vascular Endothelial Barrier Protection Prevents Atrial Fibrillation by Preserving Cardiac Nanostructure
JACC: Clinical Electrophysiology · 2023
DOI: 10.1016/j.jacep.2023.10.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2023. Verfasst von Louisa Mezache und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Nanostructures. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, American Heart Association Inc.
Abstract (Originalsprache)
BACKGROUND: Atrial fibrillation (AF), the most common cardiac arrhythmia, is widely associated with inflammation, vascular dysfunction, and elevated levels of the vascular leak-inducing cytokine, vascular endothelial growth factor (VEGF). Mechanisms underlying AF are poorly understood and current treatments only manage this progressive disease, rather than arresting the underlying pathology. The authors previously identified edema-induced disruption of sodium channel (NaV1.5)-rich intercalated disk nanodomains as a novel mechanism for AF initiation secondary to acute inflammation. Therefore, we hypothesized that protecting the vascular barrier can prevent vascular leak-induced atrial arrhythmias. OBJECTIVES: In this study the authors tested the hypothesis that protecting the vascular barrier can prevent vascular leak-induced atrial arrhythmias. They identified 2 molecular targets for vascular barrier protection, connexin43 (Cx43) hemichannels and pannexin-1 (Panx1) channels, which have been implicated in cytokine-induced vascular leak. METHODS: The authors undertook in vivo electrocardiography, electron microscopy, and super-resolution light microscopy studies in mice acutely treated with a clinically relevant level of VEGF. RESULTS: AF incidence was increased in untreated mice exposed to VEGF relative to vehicle control subjects. VEGF also increased the average number of AF episodes. VEGF shifted NaV1.5 signal to longer distances from Cx43 gap junctions, measured by a distance transformation-based spatial analysis of 3-dimensional confocal images of intercalated disks. Similar effects were observed with NaV1.5 localized near mechanical junctions composed of neural cadherin. Blocking connexin43 hemichannels (αCT11 peptide) or Panx1 channels (PxIL2P peptide) significantly reduced the duration of AF episodes compared with VEGF alone with no treatment. Concurrently, both peptide therapies preserved NaV1.5 distance from gap junctions to control levels and reduced mechanical junction-adjacent intermembrane distance in these hearts. Notably, similar antiarrhythmic efficacy was also achieved with clinically-relevant small-molecule inhibitors of Cx43 and Panx1. CONCLUSIONS: These results highlight vascular barrier protection as an antiarrhythmic strategy following inflammation-induced vascular leak.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, Ohio, USA.
- Fralin Biomedical Research Institute at VTC, Centre for Vascular and Heart Research, Virginia Tech, Roanoke, Virginia, USA; Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, USA; Virginia Tech Cari…
- Department of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, Virginia, USA; Robert M. Berne Cardiovascular Research Center, University of Virginia School of Med…
- Department of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, Ohio, USA; The Frick Center for Heart Failure and Arrhythmia, Dorothy M. Davis Heart and Lung Research Institute, Colleg…
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- American Heart Association Inc
Zitieren
APA
Mezache, L., Soltisz, A. M., Johnstone, S. R., Isakson, B. E., & Veeraraghavan, R. (2023). Vascular Endothelial Barrier Protection Prevents Atrial Fibrillation by Preserving Cardiac Nanostructure. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2023.10.013
Vancouver
Mezache L, Soltisz AM, Johnstone SR, Isakson BE, Veeraraghavan R. Vascular Endothelial Barrier Protection Prevents Atrial Fibrillation by Preserving Cardiac Nanostructure. JACC: Clinical Electrophysiology. 2023. doi:10.1016/j.jacep.2023.10.013
BibTeX
@article{Mezache2023,
author = {Mezache, Louisa and Soltisz, Andrew M and Johnstone, Scott R and Isakson, Brant E and Veeraraghavan, Rengasayee},
title = {Vascular Endothelial Barrier Protection Prevents Atrial Fibrillation by Preserving Cardiac Nanostructure},
journal = {JACC: Clinical Electrophysiology},
year = {2023},
doi = {10.1016/j.jacep.2023.10.013}
}
EUVIMED